YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Tarka® Overdose in a Young Child

dc.authorid Akbayram, Sinan/0009-0001-0816-4144
dc.authorid Uner, Abdurrahman/0000-0002-7898-6469
dc.authorid Akbayram, Sinan/0000-0001-7410-4310
dc.authorscopusid 14526773500
dc.authorscopusid 26640178300
dc.authorscopusid 26025132600
dc.authorscopusid 6602406361
dc.authorscopusid 7101877722
dc.authorscopusid 7004442897
dc.authorscopusid 7004442897
dc.authorwosid Akbayram, Sinan/Aag-5737-2020
dc.contributor.author Dogan, Murat
dc.contributor.author Basaranoglu, Murat
dc.contributor.author Peker, Erdal
dc.contributor.author Akbayram, Sinan
dc.contributor.author Sahin, Musa
dc.contributor.author Uner, Abdurrahman
dc.contributor.author Caksen, Huseyin
dc.date.accessioned 2025-05-10T17:26:05Z
dc.date.available 2025-05-10T17:26:05Z
dc.date.issued 2011
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Dogan, Murat; Basaranoglu, Murat; Peker, Erdal; Akbayram, Sinan] Yuzuncu Yil Univ, Dept Pediat, Sch Med, Van, Turkey; [Sahin, Musa] Yuzuncu Yil Univ, Dept Cardiol, Sch Med, Van, Turkey; [Uner, Abdurrahman] Yuzuncu Yil Univ, Dept Pediat Cardiol, Sch Med, Van, Turkey; [Caksen, Huseyin] Yuzuncu Yil Univ, Dept Pediat Neurol, Sch Med, Van, Turkey en_US
dc.description Akbayram, Sinan/0009-0001-0816-4144; Uner, Abdurrahman/0000-0002-7898-6469; Akbayram, Sinan/0000-0001-7410-4310 en_US
dc.description.abstract Tarka (R) is a combination antihypertensive medication composed of verapamil hydrochloride and trandolapril. A 3.5-year-old female was brought to our hospital due to a sleepy condition 7 hours after an accidental ingestion of six tablets of Tarka (R) containing 240 mg verapamil hydrochloride and 4 mg trandolapril in each tablet. Five hours after hospitalization, her condition deteriorated and arterial pressure progressively decreased despite the treatment. Finally, a temporary pacemaker was implanted, after which the vital findings began to return to normal values. The pacemaker was removed 13 hours after implantation as normal heart rhythm was observed. There are no reports of intoxication with fixed-dose combination products, especially Tarka (R), in young children in the literature. Therefore, we believe that our report can provide an insight on the toxic dose of this drug in younger children. Clinicians should keep in mind that lethargy can be the first symptom of a possible clinical deterioration, even in normotensive and normorhythmic individuals. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.1177/0960327110389834
dc.identifier.endpage 1398 en_US
dc.identifier.issn 0960-3271
dc.identifier.issn 1477-0903
dc.identifier.issue 9 en_US
dc.identifier.pmid 21148598
dc.identifier.scopus 2-s2.0-80052537536
dc.identifier.scopusquality Q2
dc.identifier.startpage 1392 en_US
dc.identifier.uri https://doi.org/10.1177/0960327110389834
dc.identifier.uri https://hdl.handle.net/20.500.14720/11572
dc.identifier.volume 30 en_US
dc.identifier.wos WOS:000294473300027
dc.identifier.wosquality Q3
dc.language.iso en en_US
dc.publisher Sage Publications Ltd en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Tarka (R) Overdose en_US
dc.subject Young Children en_US
dc.title Tarka® Overdose in a Young Child en_US
dc.type Article en_US

Files